1-Bromo-3,6,9,12-tetraoxapentadec-14-yne, 95%, 100mg

1-{[(prop-2-en-1-yl)amino]methyl}naphthalen-2-ol, 95.0%, 10g

9-(TETRAHYDROFURAN-2-YL)-9H-PURIN-6-AMINE, >99%, 250mg

5-[(2-ethyl-6-methylphenyl)amino]-2,3-dihydro-1,3,4-thiadiazole-2-thione, 97%, 100mg

3-Chloro-5-methoxyphenylisocyanide, 1g

G2F 2AB (500pmol/vial)1vial

N-(4-((4-Chloro-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)thio)phenyl)cyclopropanecarboxamide, 95.0%, 1g

(E)-4-(5-(2-(3-METHYLBENZYLIDENE)HYDRAZINYL)-2-(PYRIDIN-4-YL)PYRAZOLO[1,5-A]PYRIMIDIN-7-YL)MORPHOLINE, 95%, 2mg

2-Bromo-4-thiazolecarboxylic acid, 97.0%, 100g

(piperidin-4-yl)methyl 4-fluoro-4-(hydroxymethyl)piperidine-1-carboxylate hydrochloride, 97.0%, 100mg

(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-3-(TETRAHYDRO-2H-PYRAN-4-YL)PROPANOIC ACID, 95.0%, 250mg

5-Hexyldihydrofuran-2(3H)-one, 95.0%, 5g

Ethyl 4-methyl-1H-pyrrole-3-carboxylate, 95.0%, 1g